Effect of electroacupuncture on anti-Mullerian hormone expression in rats with polycystic ovarian syndrome

被引:1
|
作者
Zhou Jing [1 ]
Sun Yi [1 ,2 ]
Sun Jie
Zhao Ji-meng [1 ]
Cui Yun-hua [1 ]
Wu Ling-xiang [3 ]
Wu Huan-gan [1 ]
Shi Yin [1 ,3 ]
Li Liang [4 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Shanghai 201203, Peoples R China
[2] Shanghai Songjiang Dist Cent Hosp, Shanghai 201600, Peoples R China
[3] Shanghai Res Inst Acupuncture & Meridian, Shanghai 200030, Peoples R China
[4] China Acad Chinese Med Sci, Beijing 100700, Peoples R China
关键词
Acupuncture Therapy; Electroacupuncture; Point; Zhongji (CV 3); Guanyuan (CV 4); Anti-Mullerian Hormone; Polycystic Ovary Syndrome; Follicle Stimulating Hormone; Rats; GRANULOSA-CELLS; WOMEN; AMH; ACUPUNCTURE; FSH; PATHOPHYSIOLOGY; STEROIDOGENESIS; ESTRADIOL; ESTROGEN; ARREST;
D O I
10.1007/s11726-019-1094-y
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
ObjectiveTo observe whether the effect of electroacupuncture (EA) on improving sex hormone disorders and follicle development is by decreasing the expression of anti-Mullerian hormone (AMH) in rats with experimental polycystic ovarian syndrome (PCOS).MethodsForty rats were randomly divided into four groups, a normal group (NG), a model group (MG), an EA at acupoints group (EAAG), and an EA at non-acupoints group (EANAG), with 10 rats in each group. The rats in the EAAG and EANAG were intervened by EA treatment for consecutive 14 d. Zhongji (CV 3) and Guanyuan (CV 4) were selected as the acupoints in the EAAG, and the tip of the tail and 1 cm up from the tail tip were selected as the non-acupoints in the EANAG. After treatment, the histomorphological changes of the ovary, the levels of aromatase P450 (P450arom), testosterone and estradiol in the ovarian tissues, and the expressions of follicle stimulating hormone (FSH) and AMH were observed.ResultsAfter treatment, compared with the MG and EANAG, the expression of AMH decreased (P<0.05), the levels of P450arom and estradiol increased significantly, and the level of testosterone decreased significantly (all P<0.01) in the EAAG. Additionally, several normal follicles were present and the number of cystically dilated follicles decreased in the EAAG. Compared with the MG and EANAG, the EAAG obviously had more follicular granulosa cells.ConclusionEA can down-regulate the abnormally increased expression of AMH to improve sex hormone disorders and follicle development in PCOS rats.
引用
收藏
页码:80 / 88
页数:9
相关论文
共 50 条
  • [1] Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome
    Koeninger, Angela
    Koch, L.
    Edimiris, P.
    Enekwe, A.
    Nagarajah, J.
    Kasimir-Bauer, S.
    Kimmig, R.
    Strowitzki, T.
    Schmidt, B.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (05) : 1023 - 1030
  • [2] Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome
    Angela Köninger
    L. Koch
    P. Edimiris
    A. Enekwe
    J. Nagarajah
    S. Kasimir-Bauer
    R. Kimmig
    T. Strowitzki
    B. Schmidt
    Archives of Gynecology and Obstetrics, 2014, 290 : 1023 - 1030
  • [3] Anti-mullerian hormone in the pathophysiology and diagnosis of polycystic ovarian syndrome
    Dumont, Agathe
    Robin, Geoffroy
    Dewailly, Didier
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2018, 25 (06) : 377 - 384
  • [4] Serum anti-Mullerian hormone as a predictive marker of polycystic ovarian syndrome
    Parco, Sergio
    Novelli, Caterina
    Vascotto, Fulvia
    Princi, Tanja
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2011, 4 : 759 - 763
  • [5] Advantages of Serum Anti-Mullerian Hormone as a Marker for Polycystic Ovarian Syndrome
    Shi, Xinyan
    Peng, Duo
    Liu, Yanfei
    Miao, Xiaofen
    Ye, Hui
    Zhang, Jun
    LABORATORY MEDICINE, 2019, 50 (03) : 236 - 242
  • [6] Anti-Mullerian hormone and polycystic ovary syndrome
    Lebkowska, Agnieszka
    Kowalska, Irina
    ENDOKRYNOLOGIA POLSKA, 2017, 68 (01) : 74 - 78
  • [7] Anti-Mullerian hormone and polycystic ovary syndrome
    Catteau-Jonard, S.
    Dewailly, D.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2011, 39 (09): : 514 - 517
  • [8] Anti-Mullerian Hormone: A Marker of Ovarian Reserve and its Association with Polycystic Ovarian Syndrome
    Verma, Anil Kumar
    Rajbhar, Sarita
    Mishra, Jyoti
    Gupta, Mayank
    Sharma, Mratunjai
    Deshmukh, Geeta
    Ali, Wahid
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2016, 10 (12) : QC10 - QC12
  • [9] Use of anti-Mullerian hormone for understanding ovulatory dysfunction in polycystic ovarian syndrome
    Mathyk, Begum Aydogan
    Cetin, Esra
    Yildiz, Bulent O.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2022, 29 (06) : 528 - 534
  • [10] ANTI-MULLERIAN HORMONE AS A DIAGNOSTIC TOOL FOR POLYCYSTIC OVARIAN SYNDROME IN ADOLESCENT POPULATION
    Lim, Jin Whan
    Brill, Susan
    Shanazarian, Meghedy
    Samonte, Kimberly
    JOURNAL OF ADOLESCENT HEALTH, 2019, 64 (02) : S48 - S49